Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger

Immunology and Cell Biology - Tập 90 Số 7 - Trang 668-675 - 2012
Charlotte E. Egan1, Sara Cohen1, Eric Denkers1
1Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA

Tóm tắt

Oral infection of certain inbred mouse strains with the protozoan Toxoplasma gondii triggers inflammatory pathology resembling lesions seen during human inflammatory bowel disease, in particular Crohn's disease (CD). Damage triggered by the parasite is largely localized to the distal portion of the small intestine, and as such is one of only a few models for ileal inflammation. This is important because ileal involvement is a characteristic of CD in over two‐thirds of patients. The disease induced by Toxoplasma is mediated by Th1 cells and the cytokines tumor necrosis factor‐α and interferon‐γ. Inflammation is dependent upon IL‐23, also identified by genome‐wide association studies as a risk factor in CD. Development of lesions is concomitant with emergence of E. coli that display enhanced adhesion to the intestinal epithelium and subepithelial translocation. Furthermore, depletion of gut flora renders mice resistant to Toxoplasma‐triggered ileitis. Recent findings suggest complex CCR2‐dependent interactions between lamina propria T cells and intraepithelial lymphocytes in fueling proinflammatory pathology in the intestine. The advantage of the Toxoplasma model is that disease develops rapidly (within 7–10 days of infection) and can be induced in immunodeficient mice by adoptive transfer of mucosal T cells from infected donors. We propose that Toxoplasma acts as a trigger setting into motion a series of events culminating in loss of tolerance in the intestine and emergence of pathogenic T cell effectors. The Toxoplasma trigger model is providing new leaps in our understanding of immunity in the intestine.

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(07)60750-8

10.1146/annurev-immunol-030409-101225

10.1038/nature06005

10.1136/gut.2008.163667

10.1016/S1471-4914(01)02194-3

10.1053/j.gastro.2008.09.012

10.1007/s00535-009-0191-y

Blonski W, 2011, Inflammatory bowel disease therapy: current state‐of‐the‐art, Curr Opin Gastroenterol, 27, 346

10.1038/nrd1986

10.1159/000228575

10.1016/j.ijmm.2009.08.004

10.1038/nrmicro2403

10.1002/ibd.20667

10.1146/annurev.immunol.20.100301.064816

10.1016/S1074-7613(00)80038-2

10.4049/jimmunol.170.8.3939

10.1016/S1471-4914(03)00052-2

10.1016/B978-012369542-0/50003-9

10.1016/B978-012369542-0/50007-6

10.1016/S0140-6736(04)16412-X

10.1016/B978-012369542-0/50006-4

10.1086/590149

Sher A, 1993, Toxoplasma gondii induces a T‐independent IFN‐g response in NK cells which requires both adherent accessory cells and TNF‐a, J Immunol, 150, 3982, 10.4049/jimmunol.150.9.3982

10.1073/pnas.90.13.6115

Gazzinelli RT, 1994, Parasite‐induced IL‐12 stimulates early IFN‐g synthesis and resistance during acute infection with Toxoplasma gondii, J Immunol, 153, 2533, 10.4049/jimmunol.153.6.2533

10.1128/CMR.11.4.569

Bliss SK, 1999, Human polymorphonuclear leukocytes produce IL‐12, TNF‐a, and the chemokines macrophage‐inflammatory protein‐1a and ‐1b in response to Toxoplasma gondii antigens, J Immunol, 162, 7369, 10.4049/jimmunol.162.12.7369

10.4049/jimmunol.177.1.31

10.4049/jimmunol.168.12.5997

10.4049/jimmunol.181.5.3464

10.1111/j.1462-5822.2005.00517.x

10.1073/pnas.1011549108

10.4049/jimmunol.179.2.1129

10.4049/jimmunol.172.11.6954

10.4049/jimmunol.176.12.7589

Mun H‐S, 2003, TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection, Int Parasitol, 15, 1081

10.1126/science.1109893

10.1016/j.chom.2008.01.001

10.1074/jbc.M110.171025

10.4049/jimmunol.149.1.175

10.1126/science.3128869

Suzuki Y, 1988, Dual regulation of resistance against Toxoplasma gondii infection by Lyt‐2+ and Lyt1+,L3T4+ T cells in mice, J Immunol, 140, 3943, 10.4049/jimmunol.140.11.3943

10.4049/jimmunol.159.4.1903

10.1128/IAI.72.8.4432-4438.2004

10.1128/IAI.72.3.1257-1264.2004

10.4049/jimmunol.172.1.457

10.1084/jem.185.7.1261

10.1371/journal.ppat.1000288

10.1016/j.mib.2011.07.002

10.1186/gb-2005-6-11-r92

10.1146/annurev.immunol.15.1.323

10.1172/JCI28796

10.4049/jimmunol.171.12.6750

10.1038/nri1057

10.1038/nri3007

10.4049/jimmunol.181.12.8485

10.1182/blood-2005-02-0666

10.1111/j.1462-5822.2006.00735.x

10.1016/j.immuni.2008.05.019

10.1016/j.chom.2010.11.005

10.1111/j.1365-2249.2009.03876.x

10.1016/j.chom.2009.06.005

10.4049/jimmunol.177.12.8785

Chardes T, 1994, Toxoplasma gondii oral infection induces specific cytotoxic CD8a/b+ Thy‐1+ gut iintraepithelial lymphocytes, lytic for parasite‐infected enterocytes, J Immunol, 153, 4596, 10.4049/jimmunol.153.10.4596

10.1053/gast.2001.22432a

Buzoni‐Gatel D, 1999, Intraepithelial lymphocytes traffic to the intestine and enhance resistance to Toxoplasma gondii oral infection, J Immunol, 162, 5846, 10.4049/jimmunol.162.10.5846

10.1016/S0016-5085(03)00903-X

Lepage AC, 1998, Gut‐derived intraepithelial lymphocytes induce long term immunity against Toxoplasma gondii, J Immunol, 161, 4902, 10.4049/jimmunol.161.9.4902

10.4049/jimmunol.168.6.2988

10.1002/eji.200324416

10.1053/j.gastro.2006.06.003

10.1084/jem.184.2.597

10.1590/S0074-02762009000200015

10.1073/pnas.94.25.13955

10.1046/j.1365-3024.1999.00237.x

10.1371/journal.ppat.0020049

10.1002/eji.200424993

10.1084/jem.20090900

10.1172/JCI21404

10.1126/science.1135245

10.1097/00054725-200501000-00003

10.1111/j.1749-6632.1998.tb11139.x

10.1053/j.gastro.2005.09.017

10.1016/j.immuni.2008.11.003

10.1038/nm1720

10.1152/ajpgi.00513.2005

10.1002/ibd.20315

10.1086/653738

10.1128/IAI.73.1.617-621.2005

Gazzinelli RT, 1996, In the absence of endogenous IL‐10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent upon CD4+ T cells and accompanied by overproduction of IL‐12, IFN‐g, and TNF‐a, J Immunol, 157, 798, 10.4049/jimmunol.157.2.798

10.4049/jimmunol.164.10.5375

10.1038/mi.2010.27

10.1016/j.immuni.2009.10.001

10.1084/jem.20062175

10.1016/j.chom.2009.11.003

10.1053/j.gastro.2004.04.061

10.1172/JCI200420295

10.1128/JCM.43.7.3380-3389.2005

10.1136/gut.19.2.108

10.1097/00042737-200012030-00002

10.1016/S0016-5085(00)70362-3

10.1038/mi.2009.105

10.1371/journal.pone.0009125

10.1007/s00535-004-1492-9

10.1152/ajpgi.00328.2004

10.1016/j.cell.2004.07.002

10.1136/gut.2006.104497

10.1093/intimm/dxl099

10.4049/jimmunol.0901642

10.2353/ajpath.2008.080129

10.1136/gut.2003.028225

10.2741/2789

10.1053/j.gastro.2006.06.041

10.1053/j.gastro.2006.05.018

10.1053/j.gastro.2006.05.015

10.1007/s004230050268

10.1006/clin.1996.0022

10.1038/mi.2011.31

10.4049/jimmunol.173.4.2725

10.1016/j.chom.2011.04.015

10.1111/j.1365-3024.2009.01122.x

10.1016/S0140-6736(06)68265-2

10.1016/S0140-6736(76)91024-2

10.1084/jem.20091233

10.1111/j.1749-6632.2009.04673.x

10.1086/338006

10.1038/sj.gene.6363735

10.1007/s004390100462

Thông tin
Thông tin xuất bản

Immunology and Cell Biology

Tập 90 Số 7

668-675

Thông tin tác giả